Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

Brief: Eris Lifesciences Ltd Launchs Generic Semaglutide Under The Brand ‘Sundae’ In India

March 20 (Reuters) - Eris Lifesciences Ltd ERIS.NS:

ERIS LIFESCIENCES LTD - LAUNCHS GENERIC SEMAGLUTIDE UNDER THE BRAND ‘SUNDAE’ IN INDIA.

ERIS LIFESCIENCES - INTRODUCING SUNDAE IN MULTI-DOSE VIAL FORMATS STARTING AT 1,290 RUPEES PER MONTH

Source text: [ID:]

Further company coverage: ERIS.NS

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Eris Lifesciences

See all news